Alert: Major Price Advance (11/14/23)-Sanara Medtech Inc (NASDAQ: SMTI).


Sanara Medtech Inc (NASDAQ: SMTI) stock closed at $34.10 on 11/14/23 after a major increase of 19.4%. Relative to the market the stock has been weak over the last nine months but has risen 27.4% during the last week.


Current PriceTarget Research Rating

SMTI is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.

Sanara Medtech has a current Value Trend Rating of F (Lowest Rating). The Value Trend Rating reflects complementary signals from PTR’s two proprietary measures of a stock’s attractiveness. Sanara Medtech has a slightly negative Power Rating of 31 and a very low Appreciation Score of 7, and the Lowest Value Trend Rating results.

Rating Review

In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.

Be the first to comment

Leave a Reply

Your email address will not be published.